ACTIVITY OF HIF PATHWAY IN EPIDERMIS AS CONTROL FACTOR FOR SKIN VASCULATURE

DOI: https://doi.org/None

Panteleyev A.A., Usakin L.A., Tverye E.A., Chikitkina Yu.A., Rudayk S.G., Paltsev M.A.

Introduction. The physiological state of the skin vasculature is largely determined by the influence of environmental factors, including the alteration of the oxygen partial pressure. Obviously, the epidermis, as the surface layer of the skin, should play a key role in controlling signals affecting on functions of the underlying dermis. However, molecular mechanisms of both epidermis interaction with the dermis and influence of the epidermis on the dermal vasculature remain unclear. The aim of the study was to identify the role of Arnt, a key component of HIF (hypoxia induced factor) pathway for angiogenesis in dermis in mammalians. Methods. As an experimental model, we used mice with suppressed expression of the Arnt gene in the epidermis (Arntflox/floxK14-Cre+). Methods of analysis, histology and immunohistochemistry, as well as standard methods for quantifying the level of gene expression were used. Results. The ablation of Arnt protein expression in the mouse epidermis leads to severe disturbances in the vascular network of the dermis, where the Arnt level remains normal. These disorders are similar to effects on the human skin of anticoagulants as well as with manifestations of some genetic diseases of the vascular system. A significant decrease in von Willebrand factor was detected in the endothelium of the dermal blood vessels of Arnt-KO mice. A significant number of dermal vessels simultaneously expressed CD31, a marker of endothelial cells of the circulatory system and a marker of lymphatic endothelial cells - Lyve1 what indicates to serious vascular pathologies and leads to endothelial dysfunction. Thus, our data indicate to the fact that the loss of Arnt in the epidermis activates the aberrant paracrine regulatory pathway responsible for the dermal vasculature phenotype in Arntflox/floxK14-Cre+ mice. Conclusion. The considered significant role of Arnt in the adaptive response to environmental influences and the similarity between the dermal vascular network phenotype in Arntflox/floxK14-Cre+ mice and the specific vascular signs of tumor stroma and psoriatic skin, Arnt-dependent regulatory cascade can be considered as a potential target for the development of new agents for the treatment of skin pathologies sensitive to the environment. Laboratory animals and cell lines with altered activity of the Arnt gene are a promising model for studying the vascular system of skin and may reveal the role of micro- and macro environmental factors in the control of skin vasculature and pathogenesis of skin diseases.
Keywords: 
Arnt, epidermis, dermis, HIF pathway
Список литературы: 
  1. Bhushan M., Young H.S., Brenchley P.E. et al. Recent advances in cutaneous angiogenesis. Br. J. Dermatol. 2002; 147:418–25.
  2. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 2000; 24 (1): 78–84.
  3. Wong B.J., Minson C.T. Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans. J. Physiol. 2006; 577: 1043–51.
  4. Yano K., Kadoya K., Kajiya K. et al. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br. J. Dermatol. 2005; 152: 115–21.
  5. Barnhill R.L., Parkinson E.K., Ryan T.J. Supernatants from cultured human epidermal keratinocytes stimulate angiogenesis. Br. J. Dermatol. 1984; 110: 273–81.
  6. Malhotra R., Stenn K.S., Fernandez L.A. et al. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest. 1989; 61: 162–5.
  7. Detmar M., Brown L.F., Claffey K.P. et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 1994; 180: 1141–6.
  8. Detmar M., Brown L.F., Schon M.P. et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest Dermatol. 1998; 111: 1–6.
  9. Elson D.A., Thurston G., Huang L.E. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001; 15: 2520–32.
  10. Boutin A.T., Weidemann A., Fu Z. et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell. 2008; 133: 223–34.
  11. Semenza G.L. Signal transduction to hypoxia- inducible factor 1. Biochem. Pharmacol. 2002; 64: 993–7.
  12. Semenza G.L. Oxygen homeostasis. Wiley Interdiscip Rev Syst. Biol. Med. 2010; 2 (3): 336–61.
  13. Maltepe E., Schmidt J.V., Baunoch D. et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 1997; 386: 403–7.
  14. Geng S., Mezentsev A., Kalachikov S. et al. Targeted ablation of Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier function. J. Cell. Sci. 2006; 119: 4901–12.
  15. Wong W.J., Richardson T., Seykora J.T., Cotsarelis G., Simon M.C. Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. J. Invest Dermatol. 2015; 135 (2): 454–61.
  16. Weir L., Robertson D., Leigh I.M., Vass J.K., Panteleyev A.A. Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim Biophys Acta. 2011; 1813 (1): 60–72.
  17. Robertson E.D., Weir L., Romanowska M., Leigh I.M., Panteleyev A.A. ARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathways. J. Cell Sci. 2012; 125 (14): 3320–32.
  18. Wondimu A., Weir L., Robertson D., Mezentsev A., Kalachikov S., Panteleyev A.A. Loss of Arnt (Hif1b) in mouse epidermis triggers dermal angiogenesis, blood vessel dilation and clotting defects. Lab Invest. 2012; 92 (1):110–24.
  19. Panteleev A.A., Usakin L.A., Solov`eva E.V., Pal`cev M.A. Regulyatornyy kaskad HIF v e`pidermal`nyh keratinocitah – dinamika aktivnosti i zavisimost` ot gipoksii. Molekulyarnaya medicina. 2016; 14 (6): 52–8.
  20. Vasioukhin V., Degenstein L., Wise B., Fuchs E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci USA. 1999; 96 (15): 8551–6.
  21. Tomita S., Sinal C.J., Yim S.H., Gonzalez F.J. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol. Endocrinol. 2000; 14: 1674–81.
  22. Kozak K.R., Abbott B., Hankinson O. ARNT-deficient mice and placental differentiation. Dev Biol. 1997; 191: 297–305.
  23. Walisser J.A., Bunger M.K., Glover E. et al. Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J. Biol. Chem. 2004; 279: 16326–31.
  24. Braverman I.M., Keh A., Jacobson B.S. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J. Invest Dermatol. 1990; 95: 422–7.
  25. Mezzano D., Quiroga T., Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost. 2009; 35: 242–54.
  26. Weiss H.J., Sussman I.I., Hoyer L.W. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s disease. J. Clin. Invest. 1977; 60: 390–404.
  27. Denis C., Methia N., Frenette P.S. et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA. 1998; 95: 9524–9.